Zhu Z - Search Results

1

Cumulative incidence and risk factors of brain metastases in metastatic non-small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IMpower131, and IMpower150.

Zhou Y, Guo T, Liang F, Wang Z, Zhang J, Ni J, Zhu Z. Zhou Y, et al. Among authors: zhu z. Cancer. 2024 Aug 1;130(15):2601-2610. doi: 10.1002/cncr.35242. Epub 2024 Feb 14. Cancer. 2024. PMID: 38353467

2

Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.

Chang JY, Liu YH, Zhu Z, Welsh JW, Gomez DR, Komaki R, Roth JA, Swisher SG. Chang JY, et al. Among authors: zhu z. Cancer. 2013 Sep 15;119(18):3402-10. doi: 10.1002/cncr.28217. Epub 2013 Jun 24. Cancer. 2013. PMID: 23798353 Free PMC article.

3

Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.

Zhu ZF, Ma HL, Fan M, Bao Y, Zhuang TT, Chen M, Jiang GL, Fu XL. Zhu ZF, et al. Technol Cancer Res Treat. 2014 Jun;13(3):269-75. doi: 10.7785/tcrt.2012.500375. Epub 2013 Sep 20. Technol Cancer Res Treat. 2014. PMID: 24066952 Free article.

4

Full-dose pemetrexed plus cisplatin combined with concurrent thoracic radiotherapy for previously untreated advanced nonsquamous non-small cell lung cancer.

Zhang Q, Cai XW, Zhu ZF, Yu W, Liu Q, Feng W, Xue MC, Fu XL. Zhang Q, et al. Anticancer Drugs. 2015 Apr;26(4):456-63. doi: 10.1097/CAD.0000000000000215. Anticancer Drugs. 2015. PMID: 25646743

5

The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.

Feng W, Zhang Q, Fu XL, Cai XW, Zhu ZF, Yang HJ, Xiang JQ, Zhang YW, Chen HQ. Feng W, et al. BMC Cancer. 2015 May 2;15:348. doi: 10.1186/s12885-015-1326-6. BMC Cancer. 2015. PMID: 25934006 Free PMC article.

6

A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma.

Yu W, Chu L, Zhao K, Chen H, Xiang J, Zhang Y, Li H, Zhao W, Sun M, Wei Q, Fu X, Xie C, Zhu Z. Yu W, et al. Among authors: zhu z. J Cancer. 2017 Oct 17;8(18):3755-3763. doi: 10.7150/jca.20828. eCollection 2017. J Cancer. 2017. PMID: 29151963 Free PMC article.

7

Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2).

Ai D, Chen Y, Liu Q, Zhang J, Deng J, Zhu H, Ren W, Zheng X, Li Y, Wei S, Ye J, Zhou J, Lin Q, Luo H, Cao J, Li J, Huang G, Wu K, Fan M, Yang H, Zhu Z, Zhao W, Li L, Fan J, Badakhshi H, Zhao K. Ai D, et al. Among authors: zhu h, zhu z. BMJ Open. 2018 Oct 21;8(10):e020785. doi: 10.1136/bmjopen-2017-020785. BMJ Open. 2018. PMID: 30344165 Free PMC article.

8

Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma.

Zhang X, Yang X, Ni J, Li Y, Zou L, Chu L, Chu X, Xia F, Zhu Z. Zhang X, et al. Among authors: zhu z. Radiat Oncol. 2018 Dec 27;13(1):255. doi: 10.1186/s13014-018-1199-3. Radiat Oncol. 2018. PMID: 30587211 Free PMC article.

9

Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses.

Ni J, Li G, Yang X, Chu L, Wang J, Li Y, Zou L, Li Y, Xie C, Zhu Z. Ni J, et al. Among authors: zhu z. Radiat Oncol. 2019 Mar 13;14(1):44. doi: 10.1186/s13014-019-1240-1. Radiat Oncol. 2019. PMID: 30866974 Free PMC article.

10

Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio.

Li Y, Zhao W, Ni J, Zou L, Yang X, Yu W, Fu X, Zhao K, Zhang Y, Chen H, Xiang J, Xie C, Zhu Z. Li Y, et al. Among authors: zhu z. Ann Surg Oncol. 2019 Aug;26(8):2367-2374. doi: 10.1245/s10434-019-07489-3. Epub 2019 Jun 11. Ann Surg Oncol. 2019. PMID: 31187360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,719 results

Search Page

Filters